Monthly Archives: July 2021

FDA’s Recent Recalls: Ensuring Patient Safety

According to the US Food and Drug Administration (FDA), a ‘device recall’ is defined as, “when a manufacturer takes a correction or removal action to address an issue with the medical device that violates the FDA law”1

According to the FDA, a recall measure can be classified as1

Class I recall type is considered as the most serious type since these devices would result in serious injuries or death. Here, we elucidate this based on some real-life examples.

Some of the Recent Medical Device Recalls

The unique selling property of the Emblem subcutaneous Implantable Cardioverter Defibrillator (S-ICD) electrode (Boston Scientific) was that the lead is implanted just under the skin along the sternum, thus requiring a minimally invasive procedure. In the conventional ICD systems, the leads pass through the large veins from the surgically implanted device into the heart.

Boston Scientific is recalling the Emblem S-ICD electrode as it is associated with increased rate of fractures at a specific point distal to the proximal sensing ring (see image above).  Death can occur due to cardiac arrest as with the fractured device it is impossible to provide therapy for slowing down very fast heartbeats. The FDA reported 27 complaints of electrode body fractures, of which 26 were serious injuries and one death. Thereby, announcing a Class I recall on the Boston Scientific Emblem S-ICD electrode. This measure led to a recall of 19,919 devices that were manufactured and distributed in market between March 2016 to November 2020 2.

In another recent recall case, the manufacturing company (Philips) has voluntarily recalled its ventilator and other breathing devices indicated for patients with sleep apnoea since they posed a significant health risk. These devices were in market since 2009; however, the manufacturing company (Philips) received few complaints about the device around 2020. Further investigations revealed that these complaints rose due to the polyester-based polyurethane (PE-PUR) sound-reducing foam associated to reduce sound and vibration in these devices, which may penetrate to the device’s air pathway and, ultimately find a way to enter the body of the user either via inhalation or ingestion. In addition, the foam tends to off-gas certain chemicals which could be harmful during operation. The manufacturing company has received complaints about instances where presence of black debris/particles were observed in some of these device parts such as outlet, humidifier, tubing, and mask. These instances elevated the risk of particulate exposure in the user which irritates the skin, eye, and respiratory tract leading to headache, asthma, and adverse effects to kidneys and liver as well as possible toxic carcinogenic effects. With respect to off-gassing, the potential risks include headache/dizziness, irritation, hypersensitivity, nausea and vomiting along with possibility of toxic and carcinogenic effects. Although these issues sound serious and could be life-threatening, to date, no death has been reported due to these. The manufacturer eventually decided to recall about 4 million ventilators and breathing machines which were in market between 2009 and April 26, 20213.

Among the two examples, the first one is a typical case of a Class I type recall by FDA since there were reports of serious events and death, whereas the second one showcases that the manufacturing company was alert enough to voluntarily recall their devices on noticing complaints associated with it. Cited here were just the few examples of the recalls that were announced this year. In order to view the detailed list of all the devices that were recalled please check the below link

https://www.fda.gov/medical-devices/medical-device-recalls/2021-medical-device-recalls

How does FDA Ensure Patient Safety?

One of the pivotal roles and responsibilities of FDA include protection of public health by ensuring the safety, efficacy, and security of drugs, biological products, and medical devices. With respect to medical devices, FDA executes a robust program at every stage of a device’s life cycle to evaluate the safety of medical devices 4.

The FDA supervises the adverse event reports and other issues related to medical devices. Since the medical device market is enormous, to monitor all medical devices seamlessly, the devices are classified based on their potential risk as follows4:

Conclusion

To protect and promote public health, FDA’s Center for Devices and Radiological Health (CDRH) improvises its regulatory monitoring strategies now and then, to ensure the best effective use of the medical devices available on the US market without compromising on the quality and safety measures.

If you find our blogs to be interesting and you want to take the next step in advancing your knowledge on EU MDR and CER, consider our CER training class (link for our training class here). Our experts are also available to help you with end-to-end EU CER development and gap analysis please contact us at [email protected]

References

  1. FDA. What is a Medical Device Recall? 2021 [Available from: https://www.fda.gov/medical-devices/medical-device-recalls/what-medical-device-recall.
  2. FDA. Boston Scientific Recalls EMBLEM S-ICD Subcutaneous Electrode (Model 3501) Due to Risk of Fractures 2021 [Available from: https://www.fda.gov/medical-devices/medical-device-recalls/boston-scientific-recalls-emblem-s-icd-subcutaneous-electrode-model-3501-due-risk-fractures.
  3. FDA. Certain Philips Respironics Ventilators, BiPAP, and CPAP Machines Recalled Due to Potential Health Risks: FDA Safety Communication 2021 [Available from: https://www.fda.gov/medical-devices/safety-communications/certain-philips-respironics-ventilators-bipap-and-cpap-machines-recalled-due-potential-health-risks.
  4. FDA. Medical Device Safety Action Plan: Protecting Patients and Promoting Public Health  [Available from: https://www.fda.gov/files/about%20fda/published/Medical-Device-Safety-Action-Plan–Protecting-Patients–Promoting-Public-Health-%28PDF%29.pdf.

Diabetes Mellitus & it’s Management

Diabetes Mellitus (DM) is an endocrine metabolic disorder, characterized by elevated blood glucose level. DM is sub-classified into following categories.

  1. Type 1 Diabetes mellitus, also called as insulin dependent diabetes mellitus.
  2. Type 2 Diabetes Mellitus, also called as non-insulin dependent diabetes mellitus.

Type 1 DM

In Type 1 DM, there is no secretion of insulin by Beta cells of Islet of Langerhans in the pancreas because of the auto-immune destruction. Hence, there is no proper secretion of insulin. Type 1 DM is mainly treated by insulin replacement therapy. Symptoms of Type 1 DM include excessive thirst and hunger, blurred vision and fatigue. Frequent urination and weight loss occur in short period of time.

Diabetic complications may lead to cardiovascular diseases, retinopathy, and skin problems like foot ulcer.

Diagnosis of Type 1 DM is usually conducted by following procedure:

  1. Fasting blood sugar >126 mg/dl on two separate tests.
  2. Random blood sugar >200 mg/dl.
  3. Haemoglobin, HbA1c> 6.5 on two separate tests.

Management of Type 1 DM:

Good glycaemic control in Type 1 DM requires insulin therapy and oral hypoglycaemic agents like metformin, pioglitazone.

Diet and exercise play a crucial role in the management of DM.

Type 2 DM

In Type 2 DM, body cells not able to respond to insulin which is produce by Beta cells of the pancreas and is not able to produce insulin anymore.

Gestational Diabetes:

Gestational Diabetes is a condition in which sugar level is elevated during pregnancy.